Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2954654 | 0.87 | — | — | |
| SCHEMBL24016829 | 0.82 | — | — | |
| SCHEMBL7963169 | 0.82 | — | — | |
| SCHEMBL13297511 | 0.82 | — | — | |
| SCHEMBL776356 | 0.80 | DNM1 (0.41) | TSHROPRM1TDP1 | |
| SCHEMBL23236833 | 0.79 | TSHR (0.38) | TSHROPRM1CHRM1AKR1A1CHRM3 | |
| SCHEMBL10634837 | 0.78 | OPRM1 (0.50) | TSHROPRM1 | |
| SCHEMBL7962608 | 0.76 | — | — | |
| SCHEMBL22477465 | 0.76 | — | — | |
| SCHEMBL21727855 | 0.76 | DNM1 (0.33) | TSHROPRM1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2481760-B1 | INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2021-05-05 | — | — | EP | claimed |
| US-5147905-A | Cationic polyepoxide and epoxy resins for electrodeposition; flexibility; workability | THE DOW CHEMICAL COMPANY (US) | 1992-09-15 | — | — | US | claimed |
| EP-0483352-A1 | ADVANCED AND UNADVANCED EPOXY RESIN COMPOSITIONS, NUCLEOPHILIC DERIVATIVES THEREOF AND CURABLE AND COATING COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991018034-A1 | ADVANCED AND UNADVANCED COMPOSITIONS, NUCLEOPHILIC DERIVATIVES THEREOF AND CURABLE AND COATING COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1991-11-28 | — | — | WO | claimed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-113812024-B | Polymer electrolyte membrane, membrane electrode assembly, solid polymer electrolyte fuel cell, and method for producing polymer electrolyte membrane | 旭化成株式会社 | 2024-06-04 | — | — | CN | disclosed |
| CN-112979917-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-0000921-A1 | A method for preparing a high strength composite and fibrous web comprising a dried composite | THE DOW CHEMICAL COMPANY (US) | 1979-03-07 | — | — | EP | disclosed |
| US-4113710-A | EMULSION POLYMERIZATION | THE DOW CHEMICAL COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4056501-A | COPOLYMER | THE DOW CHEMICAL COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
| US-4017372-A | Process for electrodeposition of cross-linked polymer coatings | THE DOW CHEMICAL COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4002586-A | FROM A SULFIDE, AN ACID, AND AN EPOXIDE COPOLYMER, SULFONIUM GROUPS BOUND ON SURFACE | THE DOW CHEMICAL COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-3978140-A | PROCESS FOR THE PREPARATION OF CARBINOLS | ALDRICH-BORANES, INC. (US) | 1976-08-31 | — | — | US | disclosed |
| US-3958022-A | REMOVING HEAVY METAL IONS WITH A COMPLEXING AGENT | DANESH ANDRE | 1976-05-18 | — | — | US | disclosed |
| US-3935280-A | Reduction of amino acids in the presence of boron trifluoride | ALDRICH-BORANES, INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | TSHR 4885/4885OPRM1 4137/4885CHRM1 3134/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | TSHR 4885/4885OPRM1 4140/4885CHRM1 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.